Omega Therapeutics, Inc. (OMGA) NASDAQ
0.14
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.14
+0(+0.00%)
Currency In USD
| Previous Close | 0.14 |
| Open | 0.17 |
| Day High | 0.17 |
| Day Low | 0.14 |
| 52-Week High | 4.44 |
| 52-Week Low | 0.03 |
| Volume | 4.28M |
| Average Volume | 9.59M |
| Market Cap | 7.9M |
| PE | -0.11 |
| EPS | -1.32 |
| Moving Average 50 Days | 0.47 |
| Moving Average 200 Days | 1.21 |
| Change | 0 |
Data not available
Omega Pacific Clarifies Size of Previously Announced Private Placement
Newsfile
Mar 11, 2026 9:15 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - March 11, 2026) - Omega Pacific Resources Ltd. (CSE: OMGA) ("Omega Pacific" or the "Company") clarifies that the gross proceeds of the non-brokered private placement financing (the "Offering") announced
Omega Pacific Announces Non-Brokered Private Placement
Newsfile
Mar 10, 2026 8:20 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - March 10, 2026) - Omega Pacific Resources Ltd. (CSE: OMGA) ("Omega Pacific" or the "Company") announces a non-brokered private placement financing of up to $3,000,000 (the "Offering") to support its 2026
Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
GlobeNewswire Inc.
Oct 15, 2024 12:00 PM GMT
CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced it wi